Once-daily dosing with the OROS formulation of methylphenidate has minimal impact on tics in children with ADHD

被引：0
|
作者：
Palumbo, DR
Starr, HL
机构：
来源：
ANNALS OF NEUROLOGY | 2003年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [31] Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (ADDERALL XR), in children with ADHD
    McCracken, JT
    Biederman, J
    Greenhill, LL
    Swanson, JM
    McGough, JJ
    Spencer, TJ
    Posner, K
    Wigal, S
    Pataki, C
    Zhang, YX
    Tulloch, S
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (06): : 673 - 683
  • [32] THE IMPACT OF ONCE-DAILY DOSING ON ADHERENCE TO IMMUNOSUPPRESSIVE MEDICATION IN KIDNEY TRANSPLANT RECIPIENTS
    Obi, Yoshitsugu
    Ichimaru, Naotsugu
    Kato, Taigo
    Okumi, Masayoshi
    Kaimori, Junya
    Yazawa, Koji
    Nonomura, Norio
    Isaka, Yoshitaka
    Takahara, Shiro
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 311 - 311
  • [33] Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics
    Calcagno, Andrea
    Yilmaz, Aylin
    Cusato, Jessica
    Simiele, Marco
    Bertucci, Roberto
    Siccardi, Marco
    Marinaro, Letizia
    D'Avolio, Antonio
    Di Perri, Giovanni
    Bonora, Stefano
    AIDS, 2012, 26 (12) : 1529 - 1533
  • [34] Impact of once-daily oros hydromorphone on the sleep profile of patients with severe chronic low back pain
    Dubois, D.
    Wallace, M. S.
    Richarz, U.
    Kosinski, M.
    Thipphawong, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 238 - 239
  • [35] An observational study of once-daily modified-release methylphenidate in ADHD: Quality of life, satisfaction with treatment and adherence
    Rothenberger A.
    Becker A.
    Breuer D.
    Döpfner M.
    European Child & Adolescent Psychiatry, 2011, 20 (Suppl 2) : S257 - S265
  • [36] Once-Daily Gentamicin Dosing in Children with Febrile Neutropenia Resulting from Antineoplastic Therapy
    Inparajah, Miriam
    Wong, Cecile
    Sibbald, Cathryn
    Boodhan, Sabrina
    Atenafu, Eshetu G.
    Naqvi, Ahmed
    Dupuis, L. Lee
    PHARMACOTHERAPY, 2010, 30 (01): : 43 - 51
  • [37] Attention-deficit/hyperactivity disorder treatment with a once-daily formulation of methylphenidate: A two-year study
    Wilens, TE
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S415 - S415
  • [38] Once-daily dosing of levocabastine has comparable efficacy to twice-daily dosing in the treatment of allergic rhinitis assessed using an allergen challenge chamber
    Murdoch, Robert D.
    Bareille, Philippe
    Ignar, Diane
    Mark, Stephen
    Miller, Sam R.
    Gupta, Ashutosh
    Salapatek, Anne-Marie
    Patel, Piyush
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (10) : 811 - 818
  • [39] A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD
    Weiss, M
    Tannock, R
    Kratochvil, C
    Dunn, D
    Velez-Borras, J
    Thomason, C
    Tamura, R
    Kelsey, D
    Stevens, L
    Allen, AJ
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2005, 44 (07): : 647 - 655
  • [40] Safety, efficacy, and dosing comparison of once-daily OROS hydromorphone and immediate-release hydromorphone in patients with chronic non-cancer pain
    Bornhovd, K.
    Richarz, U.
    Berliner, M. N.
    Thipphawong, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 562 - 562
12345